AML-284 Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life SettingClinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang S285-S286 - 2023
Matteo Piccini, Giacomo Gianfaldoni, Francesco Mannelli, Barbara Scappini, Gaia Ciolli, Andrea Pasquini, Laura Fasano, Sofia Pilerci, Elisa Quinti, Francesca Crupi, Paola Guglielmelli, Alessandro Maria Vannucchi
MPN-328: Pelabresib (CPI-0610) Improved Anemia Associated with Myelofibrosis: Interim Results from the Ongoing MANIFEST Phase 2 StudyClinical Lymphoma, Myeloma and Leukemia - Tập 21 - Trang S361-S362 - 2021
Prithviraj Bose, Srdan Verstovsek, Marina Kremyanskaya, John Mascarenhas, Moshe Talpaz, Claire Harrison, Raajit Rampai, Andrea Patriarca, Vikas Gupta, Nikki Granacher, Tim Somervaille, Gary Schiller, Mark Drummond, Linda Foltz, Jonathan Lambert, Witold Prejzner, Gozde Colak, Patricia Keller, James Shao, Katarina Luptakova
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective AnalysisClinical Lymphoma, Myeloma and Leukemia - Tập 22 - Trang e947-e957 - 2022
Tamer Othman, Juan Penaloza, Shiliang Zhang, Claire E. Daniel, Daria Gaut, Caspian Oliai, Elizabeth A Brem, Abinav Baweja, Jane Ly, Jack Reid, Lauren Pinter-Brown, Matthew Lee, Haifaa Abdulhaq, Joseph Tuscano